Literature DB >> 18058817

Serous ovarian, fallopian tube and primary peritoneal cancers: a comparative epidemiological analysis.

Susan J Jordan1, Adèle C Green, David C Whiteman, Suzanne P Moore, Christopher J Bain, Dorota M Gertig, Penelope M Webb.   

Abstract

Invasive serous cancers are diagnosed in the ovary, fallopian tube and peritoneum. It is widely believed that these are variants of the same malignancy but little is known about fallopian tube and primary peritoneal cancers. A comparison of risk factors for these tumor types may shed light on common or distinct aetiological pathways involved in these types of cancer. We investigated risk factors for the three cancers using data from a large Australian population-based case-control study. We included women with incident invasive serous ovarian (n = 627), primary peritoneal (n = 129) and fallopian tube (n = 45) cancer and 1,508 control women. Participants completed a comprehensive reproductive and lifestyle questionnaire. Logistic regression was used to calculate odds ratios (ORs) and 95% confidence intervals (CIs). Hormonal contraceptive use was inversely related to risk of all three cancers. Parity and breast-feeding were also inversely related to risk of serous ovarian and fallopian tube cancer. In contrast, parous women had an increased risk of peritoneal cancer (OR = 1.8, 95%CI 0.8-3.9), and increasing parity did not lower risk. There was also no association between breast-feeding and peritoneal cancer. However, obesity was associated with a doubling of risk for peritoneal cancer alone (OR = 2.1, 95%CI = 1.3-3.4). The strikingly similar patterns of risk for serous ovarian and fallopian tube cancers and the somewhat different results for primary peritoneal cancer suggest that peritoneal cancers may develop along a different pathway. These results also call into question the role of the physical effects of ovulation in the development of serous ovarian cancer. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18058817     DOI: 10.1002/ijc.23287

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  24 in total

Review 1.  When is it safe to omit surgery in primary peritoneal cancer with small volume disease?

Authors:  Rachel Pounds; Sean Kehoe
Journal:  Curr Oncol Rep       Date:  2015-08       Impact factor: 5.075

2.  Premenopausal Hysterectomy and Risk of Ovarian Cancer in African-American Women.

Authors:  Lauren C Peres; Anthony J Alberg; Elisa V Bandera; Jill Barnholtz-Sloan; Melissa Bondy; Michele L Cote; Ellen Funkhouser; Patricia G Moorman; Edward S Peters; Ann G Schwartz; Paul D Terry; Sarah E Abbott; Fabian Camacho; Frances Wang; Joellen M Schildkraut
Journal:  Am J Epidemiol       Date:  2017-07-01       Impact factor: 4.897

3.  Breast Microcalcifications as the Only Imaging Manifestation of Metastatic Serous Peritoneal Adenocarcinoma in the Breast.

Authors:  Mary Moon-Sun Liang; Sze Yiun Teo; Mihir Gudi; Swee Ho Lim; Thida Win
Journal:  J Radiol Case Rep       Date:  2019-10-31

4.  Loss of lifestyle: health behaviour and weight changes after becoming a caregiver of a family member diagnosed with ovarian cancer.

Authors:  Vanessa L Beesley; Melanie A Price; Penelope M Webb
Journal:  Support Care Cancer       Date:  2010-12-02       Impact factor: 3.603

Review 5.  Molecular pathogenesis of endometrial and ovarian cancer.

Authors:  Melissa A Merritt; Daniel W Cramer
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

6.  Primary peritoneal serous papillary carcinoma: a clinical and pathological study.

Authors:  Qi Liu; Jing-xian Lin; Qun-li Shi; Bo Wu; Heng-hui Ma; Gui-qin Sun
Journal:  Pathol Oncol Res       Date:  2011-06-07       Impact factor: 3.201

7.  The Association Between Hysterectomy and Ovarian Cancer Risk: A Population-Based Record-Linkage Study.

Authors:  Suzanne C Dixon-Suen; Penelope M Webb; Louise F Wilson; Karen Tuesley; Louise M Stewart; Susan J Jordan
Journal:  J Natl Cancer Inst       Date:  2019-10-01       Impact factor: 13.506

8.  Primary peritoneal and ovarian cancers: an epidemiological comparative analysis.

Authors:  Delores J Grant; Patricia G Moorman; Lucy Akushevich; Rachel T Palmieri; Rex C Bentley; Joellen M Schildkraut
Journal:  Cancer Causes Control       Date:  2010-03-23       Impact factor: 2.506

9.  Reproductive characteristics in relation to ovarian cancer risk by histologic pathways.

Authors:  M A Merritt; M De Pari; A F Vitonis; L J Titus; D W Cramer; K L Terry
Journal:  Hum Reprod       Date:  2013-01-12       Impact factor: 6.918

10.  Helplessness/hopelessness, minimization and optimism predict survival in women with invasive ovarian cancer: a role for targeted support during initial treatment decision-making?

Authors:  Melanie A Price; Phyllis N Butow; Melanie L Bell; Anna deFazio; Michael Friedlander; Joanna E Fardell; Melinda M Protani; Penelope M Webb
Journal:  Support Care Cancer       Date:  2016-01-06       Impact factor: 3.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.